Literature DB >> 11907204

Decreased frequency of cytomegalovirus (CMV)-specific CD4+ T lymphocytes in simian immunodeficiency virus-infected rhesus macaques: inverse relationship with CMV viremia.

Amitinder Kaur1, Corrina L Hale, Bradley Noren, Nadine Kassis, Meredith A Simon, R Paul Johnson.   

Abstract

The frequency of cytomegalovirus (CMV)-specific CD4+ T lymphocytes was determined in CMV-seropositive rhesus macaques with or without simian immunodeficiency virus (SIV) infection by using the sensitive assays of intracellular cytokine staining and gamma interferon ELISPOT. Both techniques yielded 3- to 1,000-fold-higher frequencies of CMV-specific CD4+ T lymphocytes than traditional proliferative limiting dilution assays. The median frequency of CMV-specific CD4+ T lymphocytes in 23 CMV-seropositive SIV-negative macaques was 0.63% (range, 0.16 to 5.8%). The majority of CMV-specific CD4+ T lymphocytes were CD95(pos) and CD27(lo) but expressed variable levels of CD45RA. A significant reduction (P < 0.05) in the frequency of CMV-specific CD4+ T lymphocytes was observed in pathogenic SIV-infected macaques but not in macaques infected with live attenuated strains of SIV. CMV-specific CD4+ T lymphocytes were not detected in six of nine pathogenic SIV-infected rhesus macaques. CMV DNA was detected in the plasma of four of six of these macaques but in no animal with detectable CMV-specific CD4+ T lymphocytes. In pathogenic SIV-infected macaques, loss of CMV-specific CD4+ T lymphocytes was not predicted by the severity of CD4+ T lymphocytopenia. Neither was it predicted by the pre-SIV infection frequencies of CD45RA(neg) or CCR5(pos) CMV-specific CD4+ T lymphocytes. However, the magnitude of activation, as evidenced by the intensity of CD40L expression on CMV-specific CD4+ T lymphocytes pre-SIV infection, was three- to sevenfold greater in the two macaques that subsequently lost these cells after SIV infection than in the two macaques that retained CMV-specific CD4+ T lymphocytes post-SIV infection. Future longitudinal studies with these techniques will facilitate the study of CMV pathogenesis in AIDS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11907204      PMCID: PMC136096          DOI: 10.1128/jvi.76.8.3646-3658.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.

Authors:  K V Komanduri; J Feinberg; R K Hutchins; R D Frame; D K Schmidt; M N Viswanathan; J P Lalezari; J M McCune
Journal:  J Infect Dis       Date:  2001-03-12       Impact factor: 5.226

2.  Functional flexibility in T cells: independent regulation of CD4+ T cell proliferation and effector function in vivo.

Authors:  Y Laouar; I N Crispe
Journal:  Immunity       Date:  2000-09       Impact factor: 31.745

3.  Dynamics of CCR5 expression by CD4(+) T cells in lymphoid tissues during simian immunodeficiency virus infection.

Authors:  R S Veazey; K G Mansfield; I C Tham; A C Carville; D E Shvetz; A E Forand; A A Lackner
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 4.  The CD4(+) T cell response to HIV-1.

Authors:  L J Picker; V C Maino
Journal:  Curr Opin Immunol       Date:  2000-08       Impact factor: 7.486

5.  Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo.

Authors:  R S Veazey; I C Tham; K G Mansfield; M DeMaria; A E Forand; D E Shvetz; L V Chalifoux; P K Sehgal; A A Lackner
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Assessment of immune function by lymphoproliferation underestimates lymphocyte functional capacity in HIV patients treated with highly active antiretroviral therapy.

Authors:  N M Keane; P Price; S F Stone; M John; R J Murray; M A French
Journal:  AIDS Res Hum Retroviruses       Date:  2000-12-10       Impact factor: 2.205

7.  Development of virus-specific CD4(+) T cells during primary cytomegalovirus infection.

Authors:  R J Rentenaar; L E Gamadia; N van DerHoek; F N van Diepen; R Boom; J F Weel; P M Wertheim-van Dillen; R A van Lier; I J ten Berge
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

8.  Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy.

Authors:  D Salmon-Céron; M C Mazeron; S Chaput; N Boukli; B Senechal; N Houhou; C Katlama; S Matheron; A M Fillet; J Gozlan; C Leport; V Jeantils; F Freymuth; D Costagliola
Journal:  AIDS       Date:  2000-05-26       Impact factor: 4.177

9.  Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease.

Authors:  P Reusser; S R Riddell; J D Meyers; P D Greenberg
Journal:  Blood       Date:  1991-09-01       Impact factor: 22.113

10.  CD4(+) T cell subsets during virus infection. Protective capacity depends on effector cytokine secretion and on migratory capability.

Authors:  K J Maloy; C Burkhart; T M Junt; B Odermatt; A Oxenius; L Piali; R M Zinkernagel; H Hengartner
Journal:  J Exp Med       Date:  2000-06-19       Impact factor: 14.307

View more
  34 in total

1.  Genomic sequence of rhesus cytomegalovirus 180.92: insights into the coding potential of rhesus cytomegalovirus.

Authors:  Pierre Rivailler; Amitinder Kaur; R Paul Johnson; Fred Wang
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

2.  Ability of herpes simplex virus vectors to boost immune responses to DNA vectors and to protect against challenge by simian immunodeficiency virus.

Authors:  Amitinder Kaur; Hannah B Sanford; Deirdre Garry; Sabine Lang; Sherry A Klumpp; Daisuke Watanabe; Roderick T Bronson; Jeffrey D Lifson; Margherita Rosati; George N Pavlakis; Barbara K Felber; David M Knipe; Ronald C Desrosiers
Journal:  Virology       Date:  2006-09-07       Impact factor: 3.616

3.  Expanded tissue targets for foamy virus replication with simian immunodeficiency virus-induced immunosuppression.

Authors:  S M Murray; L J Picker; M K Axthelm; M L Linial
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  Absence of interaction between porcine endogenous retrovirus and porcine cytomegalovirus in pig-to-baboon renal xenotransplantation in vivo.

Authors:  Jay A Fishman; David H Sachs; Kazuhiko Yamada; Robert A Wilkinson
Journal:  Xenotransplantation       Date:  2018-04-06       Impact factor: 3.907

5.  Evaluation of high-throughput sequencing for identifying known and unknown viruses in biological samples.

Authors:  Justine Cheval; Virginie Sauvage; Lionel Frangeul; Laurent Dacheux; Ghislaine Guigon; Nicolas Dumey; Kevin Pariente; Claudine Rousseaux; Fabien Dorange; Nicolas Berthet; Sylvain Brisse; Ivan Moszer; Hervé Bourhy; Claude Jean Manuguerra; Marc Lecuit; Ana Burguiere; Valérie Caro; Marc Eloit
Journal:  J Clin Microbiol       Date:  2011-06-29       Impact factor: 5.948

6.  Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission.

Authors:  Kristy M Bialas; Takayuki Tanaka; Dollnovan Tran; Valerie Varner; Eduardo Cisneros De La Rosa; Flavia Chiuppesi; Felix Wussow; Lisa Kattenhorn; Sheila Macri; Erika L Kunz; Judy A Estroff; Jennifer Kirchherr; Yujuan Yue; Qihua Fan; Michael Lauck; David H O'Connor; Allison H S Hall; Alvarez Xavier; Don J Diamond; Peter A Barry; Amitinder Kaur; Sallie R Permar
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-19       Impact factor: 11.205

7.  Early induction of polyfunctional simian immunodeficiency virus (SIV)-specific T lymphocytes and rapid disappearance of SIV from lymph nodes of sooty mangabeys during primary infection.

Authors:  Mareike Meythaler; Zichun Wang; Amanda Martinot; Sarah Pryputniewicz; Melissa Kasheta; Harold M McClure; Shawn P O'Neil; Amitinder Kaur
Journal:  J Immunol       Date:  2011-03-25       Impact factor: 5.422

8.  Expression of CD8alpha identifies a distinct subset of effector memory CD4+ T lymphocytes.

Authors:  Iole Macchia; Marie-Claire Gauduin; Amitinder Kaur; R Paul Johnson
Journal:  Immunology       Date:  2006-07-12       Impact factor: 7.397

9.  Pharmacokinetics, toxicity, and functional studies of the selective Kv1.3 channel blocker 5-(4-phenoxybutoxy)psoralen in rhesus macaques.

Authors:  L E Pereira; F Villinger; H Wulff; A Sankaranarayanan; G Raman; A A Ansari
Journal:  Exp Biol Med (Maywood)       Date:  2007-11

10.  Inhibition of adaptive immune responses leads to a fatal clinical outcome in SIV-infected pigtailed macaques but not vervet African green monkeys.

Authors:  Jörn E Schmitz; Roland C Zahn; Charles R Brown; Melisa D Rett; Ming Li; Haili Tang; Sarah Pryputniewicz; Russell A Byrum; Amitinder Kaur; David C Montefiori; Jonathan S Allan; Simoy Goldstein; Vanessa M Hirsch
Journal:  PLoS Pathog       Date:  2009-12-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.